A Single Intravenous Dose Study of E3112 in Japanese Healthy Adult Male Subjects

Summary

The study (E3112/CP1) is a single-center, randomized, double-blind, placebo-controlled, single intravenous ascending dose study conducted in Japanese healthy adult males to evaluate the pharmacokinetics (PK), safety, and immunogenicity of E3112 following a single intravenous dose of E3112.

Timeline

Start

2017-01-25

Primary completion

2017-06-12

Completion

2017-11-22

Drugs

Indications

No indication recorded.